CTCF and cancer: The following transcription factors were consistently positive in more than 20 cancer types and were predicted to be the potential targets of RRM2: CBFB, E2F1, E2F6, FOXM1, HDAC1, HDAC2, SMC1A, CTCF, and RAD21.